Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-10-036051
Filing Date
2010-04-20
Accepted
2010-04-20 07:30:22
Documents
3
Effectiveness Date
2010-04-20

Document Format Files

Seq Description Document Type Size
1 DEFA14A a55852defa14a.htm DEFA14A 14327
2 GRAPHIC a55852a5585201.gif GRAPHIC 79865
3 GRAPHIC a55852a5585202.gif GRAPHIC 47978
  Complete submission text file 0000950123-10-036051.txt   192145
Mailing Address 311 BONNIE CIRCLE CORONA CA 92880
Business Address 311 BONNIE CIRCLE CORONA CA 92880 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-13305 | Film No.: 10758327
SIC: 2834 Pharmaceutical Preparations